Connect with us
Biotech news this week highlights sharp contrasts: Redcare Pharmacy posted strong growth and profitability, while Ocugen faced rising costs despite higher revenue but secured $115 million...
BioNTech shares are off to a strong start in 2026, gaining over 21 percent in both European and U.S. markets. Analysts remain optimistic, with most recommending...
Biotech stocks are currently out of favor, but analysts believe sentiment may have bottomed out, creating a buying opportunity—especially for undervalued small and mid-cap firms. Concerns...
Global markets saw mixed performances: DAX fell 0.6% to 19,909 points, pressured by BASF, BMW, and Bayer. MDAX and TecDAX also dropped. Hang Seng gained 0.7%,...